v3.25.3
Stockholders’ Equity and Redeemable Preferred Stock - Schedule of Warrants Outstanding and Exercisable (Details) - Warrant [Member]
 9 Months Ended
Sep. 30, 2025
USD ($)
$ / shares
shares
Schedule of Warrants Outstanding and Exercisable [Line Items]  
Number of Warrants, Outstanding and exercisable at beginning | shares 3,471
Weighted Average Exercise Price, Outstanding and exercisable at beginning | $ / shares $ 8,328.37
Weighted Average Remaining Life In Years, Outstanding and exercisable at beginning 4 years 6 months 10 days
Aggregate Intrinsic Value, Outstanding and exercisable at beginning | $
Number of Warrants, Issued in connection with February Offering | shares 452,746
Weighted Average Exercise Price, Issued in connection with February Offering | $ / shares $ 88.5
Weighted Average Remaining Life In Years, Issued in connection with February Offering 3 years 6 months
Aggregate Intrinsic Value, Issued in connection with February Offering | $
Number of Warrants, Issued pre-funded warrants | shares 29,529
Weighted Average Exercise Price, Issued pre-funded warrants | $ / shares
Aggregate Intrinsic Value, Issued pre-funded warrants | $
Number of Warrants, Exercise of pre-funded warrants | shares (29,529)
Weighted Average Exercise Price, Exercise of pre-funded warrants | $ / shares
Aggregate Intrinsic Value, Exercise of pre-funded warrants | $
Number of Warrants, Exercise of Series D Warrants from February Offering | shares (244,069)
Weighted Average Exercise Price,Exercise of Series D Warrants from February Offering | $ / shares $ 88.5
Aggregate Intrinsic Value, Exercise of Series D Warrants from February Offering | $
Number of Warrants, Outstanding and exercisable at Ending | shares 212,148
Weighted Average Exercise Price, Outstanding and exercisable at Ending | $ / shares $ 197.14
Weighted Average Remaining Life In Years, Outstanding and exercisable at Ending 4 years 3 months 3 days
Aggregate Intrinsic Value, Outstanding and exercisable at Ending | $